BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9624157)

  • 1. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.
    Fan CY; Pan J; Usuda N; Yeldandi AV; Rao MS; Reddy JK
    J Biol Chem; 1998 Jun; 273(25):15639-45. PubMed ID: 9624157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
    Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
    J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism.
    Qi C; Zhu Y; Pan J; Usuda N; Maeda N; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    J Biol Chem; 1999 May; 274(22):15775-80. PubMed ID: 10336479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice.
    Cook WS; Jain S; Jia Y; Cao WQ; Yeldandi AV; Reddy JK; Rao MS
    Exp Cell Res; 2001 Aug; 268(1):70-6. PubMed ID: 11461119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
    Yeldandi AV; Rao MS; Reddy JK
    Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of peroxisome proliferator-activated receptor alpha, and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice.
    Meyer K; Jia Y; Cao WQ; Kashireddy P; Rao MS
    Int J Oncol; 2002 Dec; 21(6):1175-80. PubMed ID: 12429965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.
    Meyer K; Lee JS; Dyck PA; Cao WQ; Rao MS; Thorgeirsson SS; Reddy JK
    Carcinogenesis; 2003 May; 24(5):975-84. PubMed ID: 12771043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxidation system.
    Jia Y; Qi C; Zhang Z; Hashimoto T; Rao MS; Huyghe S; Suzuki Y; Van Veldhoven PP; Baes M; Reddy JK
    J Biol Chem; 2003 Nov; 278(47):47232-9. PubMed ID: 14500732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene.
    Fan CY; Pan J; Chu R; Lee D; Kluckman KD; Usuda N; Singh I; Yeldandi AV; Rao MS; Maeda N; Reddy JK
    J Biol Chem; 1996 Oct; 271(40):24698-710. PubMed ID: 8798738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
    Aoyama T; Peters JM; Iritani N; Nakajima T; Furihata K; Hashimoto T; Gonzalez FJ
    J Biol Chem; 1998 Mar; 273(10):5678-84. PubMed ID: 9488698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomal beta-oxidation and steatohepatitis.
    Rao MS; Reddy JK
    Semin Liver Dis; 2001; 21(1):43-55. PubMed ID: 11296696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
    Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
    Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
    Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.
    Ren B; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
    J Biol Chem; 1997 Oct; 272(43):26827-32. PubMed ID: 9341113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between orphan nuclear hormone receptor RZRalpha and peroxisome proliferator-activated receptor alpha in regulation of the peroxisomal hydratase-dehydrogenase gene.
    Winrow CJ; Capone JP; Rachubinski RA
    J Biol Chem; 1998 Nov; 273(47):31442-8. PubMed ID: 9813056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor alpha-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal beta-oxidation enzymes acyl-CoA oxidase and hydratase-dehydrogenase.
    Kassam A; Capone JP; Rachubinski RA
    Mol Cell Endocrinol; 2001 May; 176(1-2):49-56. PubMed ID: 11369442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
    Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
    J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor alpha-dependent induction of cell surface antigen Ly-6D gene in the mouse liver.
    Dadras SS; Cook WS; Yeldandi AV; Cao WQ; Rao MS; Wang Z; Reddy JK
    Gene Expr; 2001; 9(4-5):173-81. PubMed ID: 11444527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis.
    Yu S; Rao S; Reddy JK
    Curr Mol Med; 2003 Sep; 3(6):561-72. PubMed ID: 14527087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome-proliferator-activated receptors as physiological sensors of fatty acid metabolism: molecular regulation in peroxisomes.
    Latruffe N; Cherkaoui Malki M; Nicolas-Frances V; Jannin B; Clemencet MC; Hansmannel F; Passilly-Degrace P; Berlot JP
    Biochem Soc Trans; 2001 May; 29(Pt 2):305-9. PubMed ID: 11356172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.